PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/3311/2/20
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Leo Pharma
An anonymous, non-contactable complainant asked the PMCPA to assess a media advisory board for Kyntheum (brodalumab) run by Leo Pharma Laboratories Ltd, referencing an MHRA investigation report.Nin…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3365/7/20
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Norgine breached ABPI Code over Feraccru email claiming major cost and nursing-time savings vs IV ir
A UK health professional complained about a promotional email for Feraccru (ferric maltol) sent via Guidelines in Practice to prescribers, commissioners and NHS decision makers.The email headline a…
Clauses: 9.1,9.2
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3399/10/20
HCP Hospitality & Meetings Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis
Novartis voluntarily admitted that a representative failed to maintain high standards in discussions about Piqray (alpelisib) with two clinicians.In June 2020, the representative proactively held t…
Clauses: 27.2,27.3
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3403/10/20
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Consilient app preview on Google
A member of the public found Consilient’s “Vitamin D Vitality” app on the Google Play Store when searching for “vitamin D”.The complainant alleged the app promoted InVita D3 (colecalcifer…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3407/10/20
Social Media & Digital Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Pharmasure breached undertaking by leaving Meriofert superiority-style claims on UK website
Ferring alleged Pharmasure breached an undertaking given in Case AUTH/3227/7/19 by continuing to display promotional claims for Meriofert (menotrophin) on its UK website.Ferring monitored the websi…
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3409/10/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous, non-contactable complainant (described as a concerned healthcare professional) complained about a promotional email and video about Lixiana (edoxaban) in NVAF, said to have been sent …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3366/7/20
Data & Publications Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer v Novartis
Bayer complained about a Novartis journal advertisement for Beovu (brolucizumab) in Eye News (April 2020), ref BRO20-CO22 (March 2020). The ad included a prominent headline claim in dark pink: “O…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3372/8/20
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bristol-Myers Squibb
A concerned UK health professional complained about a LinkedIn post by a US-based Bristol-Myers Squibb executive director that was ‘liked’ by a named UK employee (and later found to have been �…
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3417/11/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous, contactable patient found a YouTube video (a recording of a meeting held on 8 July 2020) on a page run by a medical education company; the complainant believed it was sponsored by Dai…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3438/12/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer
A concerned member of the public complained about Pfizer UK employees praising MHRA’s rapid approval of the Pfizer/BioNTech Covid-19 vaccine on social media.The complaint focused on a named senio…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3434/12/20
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
A.Menarini
A concerned UK health professional complained about a Menarini Group LinkedIn post linking to a press release about SEL24/MEN1703 pharmacodynamic data from the DIAMOND-01 trial (ASH Annual Meeting …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3410/10/20
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Ipsen breached ABPI Code after employee’s LinkedIn job title referenced Cabometyx and RCC
A contactable complainant alleged an Ipsen employee advertised Cabometyx (cabozantinib) on LinkedIn, promoting a prescription only medicine (POM) to the public.The employee’s LinkedIn profile sho…
Clauses: 9.1,26.1
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3422/11/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer
A UK health professional complained about a named Pfizer UK employee’s personal LinkedIn activity.The employee had ‘liked’ a post from the Global Pfizer LinkedIn account (posted by Pfizer US)…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3435/12/20
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Alimera
A UK health professional complained about Alimera’s Iluvien (fluocinolone acetonide) intravitreal implant website (iluvien.co.uk).The landing page offered two routes: “For UK Healthcare Profess…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3437/12/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer
A UK health professional complained about alleged promotion of a Covid-19 vaccine on LinkedIn by Pfizer Ltd.The complaint related to a named Pfizer UK employee’s personal LinkedIn account, featur…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3444/12/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Takeda
A UK health professional complained about alleged promotion of TAK-620 (maribavir) on LinkedIn by Takeda UK Limited.The complaint related to a Takeda employee (global role, physically based in the …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3445/12/20
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk Ozempic email alleged off-label promotion to under-18s (No breach)
A health professional complained about a Novo Nordisk promotional email for Ozempic (semaglutide) (ref UK20OZM00311) sent via Pulse.The email referenced SUSTAIN 7 data and included claims such as �…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3396/10/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo breached ABPI Code over out-of-date competitor safety symbol in Nilemdo FOC scheme ma
An anonymous Sanofi employee complained (in a personal capacity) about Daiichi-Sankyo promotional material for Nilemdo (bempedoic acid) used in a virtual meeting about a free-of-charge (FOC) scheme…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3446/12/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Jazz Pharmaceuticals
An anonymous, non-contactable complainant (self-described health professional) challenged content on the Sunosi (solriamfetol) HCP website (sunosi.co.uk). They alleged external hyperlinks (MHRA Yel…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3425/11/20
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AUTH/3425/11/20 & AUTH/3426/11/20
The Royal College of General Practitioners (RCGP) Overdiagnosis Group complained about a promotional email for Eliquis (apixaban) (ref PP-ELI-GBR-6974) sent jointly by Pfizer Limited and Bristol-My…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3439/12/20
Patient Organisations Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Amgen disease awareness
A health professional complained about a national newspaper advertisement placed by Amgen Ltd (ref GB-PRO-0920-00028).The ad showed an older woman and stated: “Are you up to date with your osteop…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3420/11/20
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Takeda
Takeda UK voluntarily admitted that UK health professionals (HCPs) were emailed an invitation to an educational webinar series (“The GI Summit 2020”) without UK certification.The invitation was…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3404/10/20
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Camurus
Indivior complained about Camurus’ promotion of Buvidal (buprenorphine, prolonged-release solution for injection) via a 54-page booklet of “clinical guidelines” and related webinars hosted by…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3400/10/20
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached Code over third‑party video series seen as pre‑licence promotion of inclisiran (AU
An anonymous health professional complained about a roundtable video series on a UK-based third-party cardiology website that included clinical data on inclisiran (Leqvio) before it had a marketing…
Clauses: NONE
2020 🔒 Subscribe
← Prev 15 16 17 18 19 20 21 Next → Page 18 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews